As a school nurse, you will often be the first healthcare professional parents will talk to if their child gets head lice. This is not a rare occurrence-an estimated 6 million to 12 million head lice infestations occur each year in the United States among children aged 3 to 11 years.¹

To target these infestations, treat lice differently with Ulesfia^® Lotion, an effective non-neurotoxic head lice therapy. Ulesfia^® Lotion does not contain chemical pesticides; evidence has shown that treating head lice with pesticides can possibly lead to resistance.^2,3

Ulesfia^® Lotion asphyxiates head lice in just 2 stages^2,4:

• The breathing apparatus of head lice are "stunned" open by benzyl alcohol
• Inactive ingredients infiltrate the respiratory apparatus and kill the head lice

Indication

Ulesfia^® (benzyl alcohol) Lotion is indicated for the topical treatment of head lice infestation in patients 6 months of age and older. Ulesfia^® Lotion does not have ovicidal activity.

Important Safety Information

• Intravenous administration of products containing benzyl alcohol has been associated with neonatal gasping syndrome consisting of severe metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, and death in preterm, low birth weight infants. Neonates (ie, patients less than 1 month of age or preterm infants with a corrected age of less than 44 weeks) could be at risk for gasping syndrome if treated with Ulesfia^® Lotion. Additional symptoms may include gradual neurological deterioration, seizures, intracranial hemorrhage, hematologic abnormalities, skin breakdown, hepatic and renal failure, bradycardia, and cardiovascular collapse
• Avoid eye exposure. Ulesfia^® Lotion may cause eye irritation. If Ulesfia^® Lotion comes in contact with the eyes, flush them immediately with water
• Ulesfia^® Lotion may cause allergic or irritant dermatitis
• Ulesfia^® Lotion should only be used on children (6 months of age and older) under the direct supervision of an adult. Keep out of reach of children
• Most common application site adverse reactions were: site irritation (2%), and site anesthesia and hypoesthesia (2%), and pain (1%)
• The most common adverse reactions are: pruritus, erythema, pyoderma, and ocular irritation

View full Prescribing Information for Ulesfia^® Lotion.

References: 1. Centers for Disease Control and Prevention website. Head lice information for schools. http://www.cdc.gov/parasites/lice/head.atml. Accessed July 29, 2013. 2. Meinking TL, Villar ME, Vicaria M, et al. The clinical trials supporting benzyl alcohol lotion 5% (Ulesfia™): a safe and effective topical treatment for headlice (pediculosis humanus capitis). Pediatr Dermatol. 2010;27(1):19-24. 3. Yoon KS, Gao J-R, Lee SH, et al. Permethrin-resistant human head lice, Pediculus capitis, and their treatment. Arch Dermatol. 2003;139:994-1000. 4. Ulesfia (benzyl alcohol) Lotion 5% [package insert]. Florham Park, NJ: Shionogi Inc; 2012.